ArticleThrombosis journal2026
Prevalence of obstructive sleep apnea syndrome in patients with pulmonary embolism: a prospective observational study.
Article in Thrombosis journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationship between obstructive sleep apnea syndrome (OSAS) and pulmonary embolism (PE) remains inadequately characterized, and prospective data obtained with objective sleep testing in confirmed PE patients are scarce. We aimed to determine the prevalence of OSAS in patients with radiologically confirmed PE and to compare clinical, laboratory, and polysomnographic features according to OSAS status.
methodsIn this single-center prospective observational study, 45 patients with confirmed PE (thoracic computed tomography pulmonary angiography or ventilation/perfusion scintigraphy) underwent portable polysomnography (WatchPAT 200
resultsOSAS was identified in 31 patients (68.9%): 11 mild, 12 moderate, and 8 severe. Body mass index (BMI) was significantly higher in OSAS-positive patients [median 31.2 (IQR 26.5-34.6) vs. 27.3 (24.2-30.4) kg/m²; p = 0.037]. Blood urea nitrogen was also elevated in the OSAS group [36.0 (25.1-52.0) vs. 19.5 (16.2-43.5) mg/dL; p = 0.026]. Minimum nocturnal oxygen saturation was markedly lower in OSAS patients [83.0% (79.0-86.5) vs. 91.0% (88.5-92.0); p < 0.001], as were the oxygen desaturation index and time with SpO₂ <90% (both p < 0.001). AHI correlated positively with age (r = 0.363; p = 0.014) and negatively with minimum nocturnal SpO₂ (r =- 0.753; p < 0.001). Classical Wells criteria did not differ between groups; 38.7% of OSAS-positive patients had no identifiable Wells risk factor for PE.
conclusionsOSAS was present in nearly 70% of PE patients and was associated with greater nocturnal hypoxemic burden, higher BMI, and elevated blood urea nitrogen. The absence of classical precipitating factors in a substantial proportion of OSAS-positive patients is consistent with the hypothesis that sleep-disordered breathing may be associated with an increased thrombotic risk. Further prospective studies are needed to evaluate the clinical utility and cost-effectiveness of targeted OSAS screening strategies in PE patients, particularly those without conventional risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.